セッション詳細
海外招聘講演1「Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease」
2025年11月21日(金) 14:55 〜 15:45
第1会場（朱鷺メッセ 2F メインホール）
座長：鎌谷 洋一郎(東京大学大学院新領域創成科学研究科 メディカル情報生命専攻 複雑形質ゲノム解析分野)
[IL1]Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease
○Jean-Charles Lambert
（UMR1167 – INSERM, Institut Pasteur de Lille, Université de Lille –）
◆略歴
Jean-Charles is a research director at Inserm and heads the “Search for molecular determinants of Alzheimer’s disease and related disorders” team. He is a recognized specialist in Alzheimer's disease, as his career shows（with more than 250 publications, and more than 48,000 citations）. The projects developed by his team is based on integrated approaches, including the development of epidemiological approaches, high-throughput genomic methods（genotyping, sequencing and transcriptomics）and an essential bioinformatics backbone. He coordinates the European Alzheimer&Dementia Biobank（EADB）, the world’s largest effort in genome-wide association studies, and is co-PI of the International Genomics for Alzheimer’s Project（IGAP）and the Alzheimer disease exome sequencing（ADES） consortium. His project also includes the development of relevant in vitro and in vivo experimental models from the most interesting genetic determinants that have been characterized.
（UMR1167 – INSERM, Institut Pasteur de Lille, Université de Lille –）
◆略歴
Jean-Charles is a research director at Inserm and heads the “Search for molecular determinants of Alzheimer’s disease and related disorders” team. He is a recognized specialist in Alzheimer's disease, as his career shows（with more than 250 publications, and more than 48,000 citations）. The projects developed by his team is based on integrated approaches, including the development of epidemiological approaches, high-throughput genomic methods（genotyping, sequencing and transcriptomics）and an essential bioinformatics backbone. He coordinates the European Alzheimer&Dementia Biobank（EADB）, the world’s largest effort in genome-wide association studies, and is co-PI of the International Genomics for Alzheimer’s Project（IGAP）and the Alzheimer disease exome sequencing（ADES） consortium. His project also includes the development of relevant in vitro and in vivo experimental models from the most interesting genetic determinants that have been characterized.